These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2576430)

  • 1. Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine.
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    J Hypertens; 1989 Dec; 7(12):947-54. PubMed ID: 2576430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():53-7. PubMed ID: 2534268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of rilmenidine on rats made insulin resistant and hypertensive by a high fructose diet].
    Berthault MF; Morin J; Dubar M; Ktorza A; Ferré P; Pénicaud L
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1103-6. PubMed ID: 8949387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular compliance in the DOCA-salt model of hypertension in the rat. Effects of propranolol.
    Cheav SL; Delcayre C; Besnard JC; Paolaggi F; Mouas C; Swynghedauw B
    Arch Int Pharmacodyn Ther; 1991; 314():5-24. PubMed ID: 1840461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
    Brown L; Ooi SY; Lau K; Sernia C
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
    Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
    Silambarasan T; Raja B
    Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
    Chan V; Hoey A; Brown L
    Br J Pharmacol; 2006 Aug; 148(7):902-8. PubMed ID: 16783413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
    O'Brien D; Chunduri P; Iyer A; Brown L
    Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A differential alteration in the responsiveness of isolated cardiac muscles to alpha- and beta-adrenergic agonists in DOCA-salt hypertensive rats.
    Hashimoto H; Hayashi T; Nakashima M
    J Pharmacobiodyn; 1991 Jun; 14(6):335-40. PubMed ID: 1686060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
    Jackson D; Connolly K; Batacan R; Ryan K; Vella R; Fenning A
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29932135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
    Watts SW; Fink GD
    Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.
    Park CG; Leenen FH
    J Korean Med Sci; 2001 Oct; 16(5):553-7. PubMed ID: 11641522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of antihypertensive effects of atenolol and propranolol in the spontaneously hypertensive, DOCA/saline hypertensive and renal hypertensive rats.
    Takeda K; Nakagawa Y; Chin WP; Imai S
    Jpn J Pharmacol; 1982 Apr; 32(2):283-9. PubMed ID: 7098145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
    Jpn J Pharmacol; 1996 Apr; 70(4):313-9. PubMed ID: 8774759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
    Prahalathan P; Kumar S; Raja B
    Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of norepinephrine release from vascular adrenergic neurons by oral administration of beta-blocker in DOCA-salt hypertension.
    Tsuda K; Masuyama Y
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):68-71. PubMed ID: 2007000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of two centrally-acting anti-hypertensive drugs on the quality of life.
    Fletcher AE; Beevers DG; Dollery CT; Wilkinson R; Bulpitt CJ
    Eur J Clin Pharmacol; 1991; 41(5):397-400. PubMed ID: 1684749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.